Browsing by Author "Seker, Mehmet Metin"
Now showing items 1-18 of 18
-
Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology
Demirci, Umut; Oflazoglu, Utku; Kodaz, Hilmi; Ciltas, Aydin; Kefeli, Umut; Akyol, Murat; Ozturk, Banu; Geredell, Caglayan; Seker, Mehmet Metin; Clhan, Saner; Tastekin, Dldem; Sevinc, Alper; Akinci, Muhammad Bulent; Uysal, Mukremin; Taskoylu, Burcu Yapar; Duran, Ayse Ocak; Yazici, Omer Komi; Karaoglu, Aziz; Benekli, Mustafa; Buyukberber, Suleyman (AMER SOC CLINICAL ONCOLOGY, 2014)… -
Clinicopathologic Features and Prognosis of Osteosarcoma in Turkish Adults
Seker, Mehmet Metin; Seker, Ayse; Aksoy, Sercan; Ozdemir, Nuriye; Uncu, Dogan; Zengin, Nurullah (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: Osteosarcomas are the most common solid malignancies of bone. In the last two decades there have been no concrete developments in their systemic treatment. In this trial we aimed to present our osteosarcoma ... -
Could the neutrophil to lymphocyte ratio be a poor prognostic factor for lung cancers?
Kacan, Turgut; Babacan, Nalan; Seker, Mehmet Metin; Yucel, Birsen; Behceci, Aykut; Gedikil, Mustafa Asim; Kilickap, Saadettin (AMER SOC CLINICAL ONCOLOGY, 2014)… -
The diagnostic and prognostic value of UHRF-1 and p53 in gastric cancer.
Babacan, Nalan Akgul; Egilmez, Reyhan; Yucel, Birsen; Seker, Mehmet Metin; Parlak, Ilknur; Kacan, Turgut; Bahcecl, Aykut; Cihan, Sener; Akincl, Bulent; Kilickap, Saadettin (AMER SOC CLINICAL ONCOLOGY, 2014)… -
The Diagnostic Value of the Correlation between Serum Anti-p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer
Hasbek, Zekiye; Dogan, Omer Tamer; San, Ismail; Yucel, Birsen; Seker, Mehmet Metin; Turgut, Bulent; Berk, Serdar; Silig, Yavuz (GALENOS YAYINCILIK, 2016)Objective: Mutations in the p53 gene are the most commonly observed genetic abnormalities in malignancies. The purpose of this study was to assess the diagnostic value of serum anti-p53 antibody (Ab) along with the correlation ... -
Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer
Ozaslan, Ersin; Topaloglu, Ulas Serkan; Inanc, Mevlude; Erdem, Umut Gokmen; Demir, Hacer; Arpaci, Erkan; Seker, Mehmet Metin; Karaaga, Mustafa; Kiziltepe, Melih; Eker, Baki; Ozkan, Metin (IMPRIMATUR PUBLICATIONS, 2017)Purpose: To evaluate the efficacy and adverse events with cetuximab plus FOLFOX administered as second- and third-line therapy in metastatic colorectal cancer (mCRC) patients. Methods: IPatients were administered cetuximab ... -
Investigation of Antitumor Effects of Sorafenib and Lapatinib Alone and in Combination on MCF-7 Breast Cancer Cells
Kacan, Turgut; Altun, Ahmet; Altun, Gulsah Gultekin; Kacan, Selen Baloglu; Sarac, Bulent; Seker, Mehmet Metin; Bahceci, Aykut; Babacan, Nalan (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: Breast cancer evolution and tumor progression are controlled by complex interactions between steroid receptors and growth factor receptor signaling. Aberrant growth factor receptor signaling can augment or ... -
Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors
Gumus, Mahmut; Bilici, Ahmet; Odabas, Hatice; Ustaalioglu, Bala Basak Oven; Kandemir, Nurten; Demirci, Umut; Cihan, Sener; Bayoglu, Ibrahim Vedat; Ozturk, Turkan; Turkmen, Esma; Urakci, Zurat; Seker, Mehmet Metin; Gunaydin, Yusuf; Selcukbiricik, Fatih; Turan, Nedim; Sevinc, Alper (SPRINGER, 2017)Background Currently, it is accepted that risk assessment of clinical stage I (CS I) nonseminomatous germ cell tumors (NSGCT) patient is mainly dependent on the presence of lymphovascular invasion (LVI). Initial active ... -
Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.
Bilici, Ahmet; Gumus, Mahmut; Odabas, Hatice; Kandemir, Nurten; Demirci, Umut; Cihan, Sener; Bayoglu, Ibrahim Vedat; Ustaalioglu, Bala Basak Oven; Ozturk, Turkan; Turkmen, Esma; Urakci, Zuhat; Seker, Mehmet Metin; Gunaydin, Yusuf; Selcukbiricik, Fatih; Turan, Nedim; Sevinc, Alper (AMER SOC CLINICAL ONCOLOGY, 2016)… -
Oxaliplatin and ototoxicity: is it really safe for hearing?
Yuce, Salim; Seker, Mehmet Metin; Koc, Sema; Uysal, Ismail Onder; Kacan, Turgut; Dogan, Mehtap; Dogan, Mansur; Babacan, Nalan Akgul; Kilickap, Saadettin (TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY, 2014)Background/aim: Oxaliplatin is an effective and widely used chemotherapeutic agent in the treatment of many solid tumors. The most common side effects are peripheral neuropathy, gastrointestinal toxicity, and neutropenia. ... -
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
Durnali, Ayse; Alkis, Necati; Cangur, Sengul; Yukruk, Fisun Ardic; Inal, Ali; Tokluoglu, Saadet; Seker, Mehmet Metin; Bal, Oznur; Akman, Tulay; Inanc, Mevlude; Isikdogan, Abdurrahman; Demirci, Ayse; Helvaci, Kaan; Oksuzoglu, Berna (HUMANA PRESS INC, 2013)The aim of this retrospective, multicenter study was to evaluate clinicopathological characteristics, prognostic factors and treatment outcomes of teenage and adult patients with high-grade osteosarcoma. A total of 240 ... -
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
Inal, Ali; Kodaz, Hilmi; Odabas, Hatice; Duran, Ayse Ocak; Seker, Mehmet Metin; Inanc, Mevlide; Elkiran, Emin Tamer; Gunaydin, Yusuf; Menekse, Serkan; Topcu, Turkan Ozturk; Urakci, Zuhat; Tastekin, Didem; Bilici, Mehmet; Cihan, Sener; Geredeli, Caglayan; Sezer, Emel; Uncu, Dogan; Arpaci, Erkan; Ozturk, Banu; Bal, Oznur; Uysal, Mukremin; Tanriverdi, Ozgur; Gumus, Mahmut; Ustaalioglu, Bala Basak Oven; Suner, Ali; Cokmert, Suna; Hacibekiroglu, Ilhan; Aydin, Kubra; Isikdogan, Abdurrahman (MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2018)Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ... -
Prognostic value of serum TIE-2 and vascular endothelial growth factor levels in gastric cancer patients.
Seker, Mehmet Metin; Sancakdar, Enver; Seker, Ayse; Bahceci, Aykut; Kacan, Turgut; Babacan, Nalan (AMER SOC CLINICAL ONCOLOGY, 2014)… -
The prognostic value of UHRF-1 and p53 in gastric cancer
Babacan, Nalan A.; Egilmez, Hatice Reyhan; Yucel, Birsen; Parlak, Ilknur; Seker, Mehmet Metin; Kacan, Turgut; Bahceci, Aykut; Cihan, Sener; Akinci, Bulent; Eriten, Berna; Kilickap, Saadettin (MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2016)Background/Aims: This study aimed to examine whether UHRF-1 and p53 overexpression is a prognostic marker for gastric cancer. Patients and Methods: Sixty-four patients with gastric cancer (study group) and 23 patients with ... -
Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers
Cihan, Sener; Kucukoner, Mehmet; Ozdemir, Nuriye; Dane, Faysal; Sendur, Mehmet Ali Nahit; Yazilitas, Dogan; Urakci, Zuhat; Durnali, Ayse; Yuksel, Sinemis; Aksoy, Sercan; Colak, Dilsen; Seker, Mehmet Metin; Taskoylu, Burcu Yapar; Oguz, Arzu; Isikdogan, Abdurrahman; Zengin, Nurullah (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: The standard therapy for stage I rectum cancer is surgical resection. Currently, there is no strong evidence to suggest that any type of adjuvant therapy is beneficial. The risks of local relapse and distant ... -
Survival Analysis and Prognostic Factors for Neuroendocrine Tumors in Turkey
Yucel, Birsen; Babacan, Nalan Akgul; Kacan, Turgut; Eren, Ayfer Ay; Eren, Mehmet Fuat; Bahar, Seher; Celasun, Mustafa Gurol; Seker, Mehmet Metin; Hasbek, Zekiye (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2013)Background: This study aimed to determine the demographical distribution, survival and prognostic factors for neuroendocrine tumors monitored in our clinic. Materials and Methods: Data for 52 patients who were admitted to ... -
Treatment and Outcomes of Ewing Sarcoma in Turkish Adults: A Single Centre Experience
Seker, Mehmet Metin; Kos, Tugba; Ozdemir, Nuriye; Seker, Ayse; Aksoy, Sercan; Uncu, Dogan; Zengin, Nurullah (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: Ewing sarcoma is a small round cell tumor arising from soft tissue and bone that predominantly affects children and adolescents. The most unfavorable prognostic factor is the presence of distant metastasis at ... -
What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.
Kaplan, Muhammet Ali; Urakci, Zuhat; Gumus, Mahmut; Arslan, Ulku Yalcintas; Geredeli, Caglayan; Ozdemir, Nuriye; Koca, Dogan; Oruc, Zeynep; Uysal, Mukremin; Dane, Faysal; Sevinc, Alper; Seker, Mehmet Metin; Aksoy, Asude; Kucukoner, Mehmet; Pilanci, Kezban Nur; Topcu, Turkan Ozturk; Karaagac, Mustafa; Yildiz, Ramazan; Isikdogan, Abdurrahman (AMER SOC CLINICAL ONCOLOGY, 2015)…